Troutman Pepper Advises Eupraxia Pharmaceuticals in Closing of a Non-Brokered Private Placement

WASHINGTON, D.C. – Troutman Pepper client Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet need, recently announced that it has completed a non-brokered private placement of 8,905,638 Series 1 Preferred shares of the Company, at a price of C$5.00 per Preferred Share for aggregate gross proceeds of C$44,528,190, by way of a non-brokered private placement. Read a company press release about the private placement.

The Company intends to use the net proceeds from the Private Placement towards the funding of clinical trials for EP104GI, initiating research programs for new candidates and general corporate and working capital purposes of the Company and its affiliates.

The Troutman Pepper team advising Eupraxia Pharmaceuticals was led by Thomas Rose, and included Shona Smith, Nicole Edmonds, Jason Langford, Joseph Cataldo, Judith O’Grady, Noreen Onimus, and Thomas Phelan.

Troutman Pepper is a go-to firm for life sciences transactions with a large, multidisciplinary team with a deep understanding of the space. The firm regularly advises pharmaceutical, biotech, medical device, diagnostics, and other life sciences clients on all types of corporate matters — governance and general corporate advice; M&A transactions; licensing transactions and other complex collaborations; IPOs, follow-on public offerings, PIPE transactions, and other capital markets transactions; seed and later-stage venture capital financings; and much more.

About Troutman Pepper
Troutman Pepper is a national law firm with 1,100+ attorneys strategically located in more than 20 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a diverse client base, from startups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including energy, financial services, health sciences, insurance, and private equity, among others. Learn more at troutman.com.